BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and biological assessment of acridine derivatives containing 1,3,4-thiadiazole moiety as novel selective acetylcholinesterase inhibitors. 2020

Safa Lotfi, and Talat Rahmani, and Maryam Hatami, and Behjat Pouramiri, and Esmat Tavakolinejad Kermani, and Elham Rezvannejad, and Mojtaba Mortazavi, and Shahnaz Fathi Hafshejani, and Nahid Askari, and Nader Pourjamali, and Mahboobeh Zahedifar
Department of Biotechnology, Institute of Science and High Technology and Environmental Sciences, Graduate University of Advanced Technology, Kerman, Iran. Electronic address: safalotfi@ut.ac.ir.

A novel series of acridine derivatives containing substituted thiadiazol-2-amine moiety was synthesized via multi-component condensation reaction of dimedone, aromatic aldehyde and 5-aryl-1,3,4-thiadiazol-2-amines in the presence of LaCl3 as a catalyst under solvent-free conditions. Anticholinesterase (AChE and BuChE) activity evaluation of the derivatives showed that all the derivatives are capable of inhibiting both enzymes and are highly selective towards AChE. Among them, the ability of 4i and 4d with respective IC50 values of 0.002 and 0.006 µM to inhibit AChE was higher than the reference compound tacrine (IC50 = 0.016 µM). The kinetics studies demonstrated that 4i and 4d inhibit AChE through a competitive/non-competitive mixed mechanism. The HEPG2 cell viability assay evidenced that 4i and 4d significantly exhibit lower hepatotoxicity compared with tacrine. Blind docking experiments performed on TcAChE (PDB ID: 2ACE) indicated that an unknown site is preferred for binding by all the derivatives over classic binding site of the enzyme, site 1 (CAS/PAS). Identification of the residues by protein structure alignment confirmed that this site is site 2 which was recently recognized as a new allosteric site of hAChE. The binding modes of 4i and 4d were also investigated using local docking studies on site 1 and site 2.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000110 Acetylcholinesterase An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7. Acetylcholine Hydrolase,Acetylthiocholinesterase,Hydrolase, Acetylcholine
D000166 Acridines Compounds that include the structure of acridine. Acridine
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D013619 Tacrine A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders. Tetrahydroaminoacridine,1,2,3,4-Tetrahydro-9-acridinamine,1,2,3,4-Tetrahydroaminoacridine,9-Amino-1,2,3,4-Tetrahydroacridine,Cognex,Romotal,THA,Tacrine Hydrochloride,Tenakrin
D013830 Thiadiazoles Heterocyclic compounds composed of a five-membered heterocyclic ring which contains one sulfur and two nitrogen atoms. Thiadiazole
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Safa Lotfi, and Talat Rahmani, and Maryam Hatami, and Behjat Pouramiri, and Esmat Tavakolinejad Kermani, and Elham Rezvannejad, and Mojtaba Mortazavi, and Shahnaz Fathi Hafshejani, and Nahid Askari, and Nader Pourjamali, and Mahboobeh Zahedifar
Novel amide derivatives containing 1,3,4-thiadiazole moiety: Design, synthesis, nematocidal and antibacterial activities.
May 2019, Bioorganic & medicinal chemistry letters,
Safa Lotfi, and Talat Rahmani, and Maryam Hatami, and Behjat Pouramiri, and Esmat Tavakolinejad Kermani, and Elham Rezvannejad, and Mojtaba Mortazavi, and Shahnaz Fathi Hafshejani, and Nahid Askari, and Nader Pourjamali, and Mahboobeh Zahedifar
Synthesis and Bioactivities of Novel Galactoside Derivatives Containing 1,3,4-Thiadiazole Moiety.
January 2022, Frontiers in chemistry,
Safa Lotfi, and Talat Rahmani, and Maryam Hatami, and Behjat Pouramiri, and Esmat Tavakolinejad Kermani, and Elham Rezvannejad, and Mojtaba Mortazavi, and Shahnaz Fathi Hafshejani, and Nahid Askari, and Nader Pourjamali, and Mahboobeh Zahedifar
Design, Synthesis, Antibacterial Activity, and Mechanisms of Novel 1,3,4-Thiadiazole Derivatives Containing an Amide Moiety.
August 2021, Journal of agricultural and food chemistry,
Safa Lotfi, and Talat Rahmani, and Maryam Hatami, and Behjat Pouramiri, and Esmat Tavakolinejad Kermani, and Elham Rezvannejad, and Mojtaba Mortazavi, and Shahnaz Fathi Hafshejani, and Nahid Askari, and Nader Pourjamali, and Mahboobeh Zahedifar
Novel Flavonol Derivatives Containing 1,3,4-Thiadiazole as Potential Antifungal Agents: Design, Synthesis, and Biological Evaluation.
April 2024, ACS omega,
Safa Lotfi, and Talat Rahmani, and Maryam Hatami, and Behjat Pouramiri, and Esmat Tavakolinejad Kermani, and Elham Rezvannejad, and Mojtaba Mortazavi, and Shahnaz Fathi Hafshejani, and Nahid Askari, and Nader Pourjamali, and Mahboobeh Zahedifar
Design, Synthesis and Antiproliferative Evaluation of Novel Disulfides Containing 1,3,4-Thiadiazole Moiety.
January 2017, Chemical & pharmaceutical bulletin,
Safa Lotfi, and Talat Rahmani, and Maryam Hatami, and Behjat Pouramiri, and Esmat Tavakolinejad Kermani, and Elham Rezvannejad, and Mojtaba Mortazavi, and Shahnaz Fathi Hafshejani, and Nahid Askari, and Nader Pourjamali, and Mahboobeh Zahedifar
Synthesis and bioactivities of novel thioether/sulfone derivatives containing 1,2,3-thiadiazole and 1,3,4-oxadiazole/thiadiazole moiety.
November 2013, Bioorganic & medicinal chemistry letters,
Safa Lotfi, and Talat Rahmani, and Maryam Hatami, and Behjat Pouramiri, and Esmat Tavakolinejad Kermani, and Elham Rezvannejad, and Mojtaba Mortazavi, and Shahnaz Fathi Hafshejani, and Nahid Askari, and Nader Pourjamali, and Mahboobeh Zahedifar
Novel vanillin derivatives containing a 1,3,4-thiadiazole moiety as potential antibacterial agents.
May 2020, Bioorganic & medicinal chemistry letters,
Safa Lotfi, and Talat Rahmani, and Maryam Hatami, and Behjat Pouramiri, and Esmat Tavakolinejad Kermani, and Elham Rezvannejad, and Mojtaba Mortazavi, and Shahnaz Fathi Hafshejani, and Nahid Askari, and Nader Pourjamali, and Mahboobeh Zahedifar
Synthesis and antifungal activity of novel sulfoxide derivatives containing trimethoxyphenyl substituted 1,3,4-thiadiazole and 1,3,4-oxadiazole moiety.
April 2008, Bioorganic & medicinal chemistry,
Safa Lotfi, and Talat Rahmani, and Maryam Hatami, and Behjat Pouramiri, and Esmat Tavakolinejad Kermani, and Elham Rezvannejad, and Mojtaba Mortazavi, and Shahnaz Fathi Hafshejani, and Nahid Askari, and Nader Pourjamali, and Mahboobeh Zahedifar
Synthesis and biological activities of novel 1,3,4-thiadiazole-containing pyrazole oxime derivatives.
August 2016, Bioorganic & medicinal chemistry letters,
Safa Lotfi, and Talat Rahmani, and Maryam Hatami, and Behjat Pouramiri, and Esmat Tavakolinejad Kermani, and Elham Rezvannejad, and Mojtaba Mortazavi, and Shahnaz Fathi Hafshejani, and Nahid Askari, and Nader Pourjamali, and Mahboobeh Zahedifar
Synthesis and biological evaluation of isatin derivatives containing 1,3,4-thiadiazole as potent a-glucosidase inhibitors.
December 2021, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!